South Korea Cold Plasma Market (2024-2029)
The South Korea Cold Plasma Market was valued at $4.48 Million in 2024 and projected to reach to $6.56 Million by 2029, representing a compound annual growth rate of 7.9%. South Korea's cold plasma market is poised for sustained expansion as the nation's healthcare sector increasingly embraces cutting-edge plasma technologies for wound healing, sterilization, and dermatological applications.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Cold Plasma Market Trends and Insights
- Valued at $4.48 million in 2024, South Korea's market is projected to expand to $6.56 million by 2029, reflecting a compound annual growth rate of 7.9%.
- This growth trajectory underscores South Korea's increasing adoption of advanced plasma technologies in clinical and therapeutic applications. The cold plasma market in South Korea is driven by rising healthcare investments and technological innovation in the country's medical device sector.
- South Korea's strong manufacturing capabilities and regulatory framework support the development and commercialization of cold plasma solutions.
- Between 2024 and 2029, South Korea is expected to see accelerated market penetration as healthcare providers and research institutions expand their utilization of cold plasma for wound healing, sterilization, and dermatological treatments. South Korea's position as a regional healthcare innovator positions the country favorably for cold plasma market expansion.
- The nation's emphasis on precision medicine and advanced therapeutic technologies creates a conducive environment for cold plasma adoption, with South Korea likely to emerge as a key market within the broader Asia Pacific region..
Key Market Statistics
- CAGR (2024-2029) 7.9% CAGR
- Market Size, 2024 ~USD 4.48 Million
- Forecast, 2029 ~USD 6.56 Million
- Country South Korea
South Korea Cold Plasma Market Overview
Market Valuation :
South Korea's cold plasma market reached $4.48 million in 2024, demonstrating significant investment in advanced healthcare technologies and therapeutic innovations within the region.
Growth Trajectory :
With a CAGR of 7.9% through 2029, South Korea's market is expanding faster than many developed economies, driven by healthcare modernization and increased clinical adoption of plasma-based treatments.
Regional Position :
As a key player in Asia Pacific healthcare, South Korea leverages its advanced medical infrastructure and R&D capabilities to accelerate cold plasma technology integration across clinical settings.
Forecast Growth :
The market is projected to reach $6.56 million by 2029, representing a 46% increase over five years and reflecting growing confidence in cold plasma's therapeutic potential among South Korean healthcare providers.
South Korea Cold Plasma Market Dynamics
- The country's strong emphasis on medical innovation, coupled with government support for advanced healthcare solutions, creates a favorable environment for market growth.
- South Korean hospitals and clinics are progressively integrating cold plasma systems into their therapeutic protocols, driven by clinical efficacy data and patient demand for non-invasive treatment options. Looking ahead to 2029, South Korea's cold plasma market will benefit from continued technological refinement, expanded clinical applications, and growing awareness among healthcare professionals.
- The nation's robust medical device manufacturing sector and export-oriented economy position it as a regional hub for cold plasma innovation.
- Increased collaboration between research institutions and healthcare providers will further accelerate market penetration, particularly in specialized medical centers and emerging therapeutic areas..
Market Ecosystem
COLD PLASMA MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Enables controlled plasma processing for high-precision manufacturing, improving process uniformity and supporting advanced semiconductor and electronics production. | Develops plasma generators and plasma processing technologies used in semiconductor, electronics, and thin-film manufacturing applications, including etching, deposition, and surface treatment under controlled plasma conditions. |
 |
Enables precise, automated plasma treatment for surface modification, cleaning, and adhesion improvement, supporting consistent processing and reduced use of chemical pretreatment. | Provides plasma-based surface treatment solutions used for cleaning, activation, and surface modification of plastics, metals, glass, and electronic components | These systems help improve coating and adhesive bonding while supporting automated manufacturing processes. |
 |
Improves surface energy, adhesion, and wettability while enabling inline, chemical-free surface treatment with high process consistency. | Develops atmospheric-pressure plasma systems, including Openair-Plasma, for surface cleaning, activation, functionalization, and coating preparation across automotive, electronics, medical, and polymer industries. |
 |
Develops high-performance cleanroom garments, protective materials, and barrier fabrics used in pharmaceutical, semiconductor, and microelectronics facilities. | Provides atmospheric-pressure plasma systems for surface activation, cleaning, and functionalization of plastics, composites, metals, and other materials | Its plasma solutions can be integrated into automated production lines for continuous treatment. |
 |
Provides access to specialized plasma and scientific instrumentation technologies supporting advanced research, surface treatment, and industrial processing applications. | Through its scientific-instrumentation subsidiaries, supports specialized technologies used in research, materials analysis, plasma processing, and advanced industrial applications, depending on the subsidiary and product portfolio. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- South Korea's cold plasma market is valued at $4.48 million in 2024 and is forecast to reach $6.56 million by 2029.
- South Korea demonstrates a 7.9% CAGR, reflecting moderate but consistent market expansion driven by healthcare innovation.
- South Korea's advanced medical device manufacturing and regulatory infrastructure support cold plasma technology commercialization.
- South Korea is positioned as a key regional player in cold plasma adoption within Asia Pacific healthcare.
Cold Plasma Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MEDICAL INDUSTRY (Industry) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11% from 2024 to 2029 |
| Largest Segment | ATMOSPHERIC COLD PLASMA (Regime) |
| Market Size Base Year (Billions) | ~USD 2.14 (2024) |
| Revenue Forecast (Billions) | ~USD 3.6 (2029) |
| Segments Covered | Industry, Application, Regime |
South Korea Cold Plasma Market Report Segmentation
3 segment dimensions are covered across the global market.
By Industry
- Cosmetic Industry
- Electronics & Semiconductors Industry
- Food & Agriculture Industry
- Medical Industry
- Other Industries
- Polymer & Plastic Industry
- Textile Industry
By Application
- Aesthetic Procedures
- Coating & Thin-Film Deposition
- Other Applications
- Printing
- Surface Cleaning & Decontamination
- Surface Etching
- Surface Treatment & Activation
- Surgical
- Wound Healing
By Regime
- Atmospheric Cold Plasma
- Low-Pressure Cold Plasma
Target Audience
- Medical Device Manufacturers : South Korean and international device makers need precise market data to assess expansion opportunities, benchmark competitive positioning, and develop localized cold plasma solutions for the Korean healthcare market.
- Healthcare Investors : Investment firms and venture capitalists require detailed South Korea market analysis to evaluate funding opportunities in cold plasma startups, medical technology companies, and healthcare innovation ventures.
- Hospital & Clinic Administrators : Healthcare facility leaders need market insights to justify capital investments in cold plasma equipment, understand adoption trends among peer institutions, and plan technology integration strategies.
- Market Research & Consulting Firms : Research organizations require country-specific data to support client advisory services, competitive analysis, and strategic recommendations for companies operating in South Korea's healthcare sector.
- Government & Policy Makers : South Korean health ministry officials and policy advisors need market intelligence to inform healthcare technology regulations, innovation incentives, and strategic healthcare modernization initiatives.
Reasons to Buy this Report
- Market-Specific Sizing Data : Access precise valuation figures for South Korea's cold plasma market ($4.48M in 2024) with detailed forecasts through 2029, enabling accurate budget allocation and investment planning for regional operations.
- Competitive Intelligence : Understand South Korea's unique market dynamics, local player strategies, and competitive positioning within Asia Pacific, providing actionable insights for market entry or expansion decisions.
- Growth Opportunity Assessment : Leverage the 7.9% CAGR data to identify high-potential segments within South Korea's healthcare sector and prioritize resource allocation toward the most promising therapeutic applications and customer segments.
- Regional Healthcare Trends : Gain insights into South Korea's adoption patterns of advanced plasma technologies, clinical integration rates, and healthcare provider preferences that inform product development and go-to-market strategies.
- Strategic Planning Support : Use country-specific market intelligence to develop targeted business strategies, partnership opportunities, and investment decisions tailored to South Korea's healthcare landscape and regulatory environment.
Frequently asked questions
What is the current size of South Korea's cold plasma market?
South Korea's cold plasma market was valued at $4.48 million in 2024 and is expected to grow to $6.56 million by 2029.
What is the projected growth rate for cold plasma in South Korea?
South Korea's cold plasma market is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2029.
What factors are driving cold plasma market growth in South Korea?
South Korea's cold plasma market growth is driven by increased healthcare investments, technological innovation in medical devices, and expanding clinical applications in wound healing and dermatology.
How does South Korea's cold plasma market compare to the global market?
South Korea's 7.9% CAGR is lower than the global 11% CAGR, indicating a more measured adoption pace while still maintaining steady regional growth.
What applications are driving cold plasma adoption in South Korea?
South Korea's cold plasma adoption is primarily driven by applications in wound healing, sterilization, and dermatological treatments within healthcare facilities and research institutions.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the size of the cold plasma market. Exhaustive secondary research was conducted to gather information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
The secondary research process involved the extensive use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the cold plasma technologies market. It was also used to obtain important information about key players, market classification and segmentation according to industry trends down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the cold plasma market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
The research methodology used to estimate the size of the cold plasma market is as follows.
Market sizing was conducted from a global perspective.
Country-level Analysis: The size of the cold plasma market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall cold plasma market was obtained from secondary data and validated by primary participants to arrive at the total cold plasma market. Primary participants further validated the numbers.
Geographic Market Assessment (Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall cold plasma technologies market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Data Triangulation
After determining the overall size of the global cold plasma market using the aforementioned methodology, the market was segmented into several subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and ground- and excited-state molecules. It is an innovative and convenient alternative to traditional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.
Key Stakeholders
- Cold plasma manufacturers and distributors
- Government and research organizations
- Cold plasma application industries
- Plasma technology component suppliers
- Medical device manufacturing companies
- Healthcare organizations
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
- Corporate entities
Report Objectives
- To describe, analyze, and forecast the cold plasma market by industry, application, regime, and region
- To describe and forecast the cold plasma market in key regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing market growth
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the cold plasma market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the cold plasma market
- To analyze the impact of AI/Gen AI on the cold plasma market in terms of its capabilities, potential, use cases, and future
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific cold plasma market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Europe cold plasma market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Latin America cold plasma market into Argentina, Peru, and other countries
- Further breakdown of Rest of Middle East & Africa cold plasma market into Israel, Iran, Iraq, Jordan, Yemen, and other countries.
Get the Full Cold Plasma Market Report
Full forecast, segment splits, and company analysis for all Cold Plasma Market.
- US Cold Plasma Market
- Canada Cold Plasma Market
- Germany Cold Plasma Market
- France Cold Plasma Market
- UK Cold Plasma Market
- Italy Cold Plasma Market
- Spain Cold Plasma Market
- China Cold Plasma Market
- Japan Cold Plasma Market
- India Cold Plasma Market
- Australia Cold Plasma Market
- Brazil Cold Plasma Market
- Mexico Cold Plasma Market
- Rest Of Europe Cold Plasma Market
- Rest Of Asia Pacific Cold Plasma Market
- Rest Of Latin America Cold Plasma Market
- GCC Countries Cold Plasma Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
